Great Ormond Street Hospital to Build New Research Facility
|
By HospiMedica International staff writers Posted on 20 Dec 2016 |

Image: An artist’s rendering of the Zayed Centre for Research into Rare Disease in Children (Photo courtesy of GOSH).
Great Ormond Street Hospital for Children (GOSH; London, United Kingdom) and University College London (UCL; United Kingdom) are constructing a new, state-of-the-art research center.
The Zayed Centre for Research into Rare Diseases in Children will be built adjacent to GOSH and the UCL Institute of Child Health, and will provide cutting-edge technology, equipment, and office space for up to 400 world-leading scientists and clinicians. The center will contain a variety of research laboratories to study rare diseases and develop treatments. A good manufacturing practice (GMP) facility on the fourth floor will aid laboratories to manufacture specialist products for new therapies, clinical trials, and patient treatments.
The six-story building will have a total floor space of more than 13,000m², with equipment rooms and workspaces to develop diagnostic procedures, manufacture gene and cell therapies, and to create personalized medical devices. Additional features will include a cardiology suite; a flow cytometry suite for the counting, storing, and analysis of cells with laser technology; a new outpatient clinic; and research write-up areas, meeting rooms, and spaces to allow scientists and medical teams to collaborate and progress with their work. Two large laboratories will be located on the lower ground floor.
“The really exciting thing about the new building is the possibility of creating a working environment that brings everyone together. As a clinician, I need to explore my options for treating a patient with experts who can help me develop them,” said Professor Andrew Taylor, MD, of GOSH and UCL. “A variety of different professionals under one roof will allow us to turn innovative thinking into practical solutions. The centre will also give us a manufacturing capacity to develop these solutions at scale so we can help more and more patients.”
The new research center, named in the honor of Sheikh Zayed bin Sultan Al Nahyan, the Emir of Abu Dhabi and first president of the United Arab Emirates (UAE), will operate as a partnership between Great Ormond Street Hospital, UCL, and the Great Ormond Street Hospital Children’s Charity (London, United Kingdom). Construction is scheduled to begin in January 2017 and is expected to be completed by 2018.
Related Links:
Great Ormond Street Hospital for Children
University College London
Great Ormond Street Hospital Children’s Charity
The Zayed Centre for Research into Rare Diseases in Children will be built adjacent to GOSH and the UCL Institute of Child Health, and will provide cutting-edge technology, equipment, and office space for up to 400 world-leading scientists and clinicians. The center will contain a variety of research laboratories to study rare diseases and develop treatments. A good manufacturing practice (GMP) facility on the fourth floor will aid laboratories to manufacture specialist products for new therapies, clinical trials, and patient treatments.
The six-story building will have a total floor space of more than 13,000m², with equipment rooms and workspaces to develop diagnostic procedures, manufacture gene and cell therapies, and to create personalized medical devices. Additional features will include a cardiology suite; a flow cytometry suite for the counting, storing, and analysis of cells with laser technology; a new outpatient clinic; and research write-up areas, meeting rooms, and spaces to allow scientists and medical teams to collaborate and progress with their work. Two large laboratories will be located on the lower ground floor.
“The really exciting thing about the new building is the possibility of creating a working environment that brings everyone together. As a clinician, I need to explore my options for treating a patient with experts who can help me develop them,” said Professor Andrew Taylor, MD, of GOSH and UCL. “A variety of different professionals under one roof will allow us to turn innovative thinking into practical solutions. The centre will also give us a manufacturing capacity to develop these solutions at scale so we can help more and more patients.”
The new research center, named in the honor of Sheikh Zayed bin Sultan Al Nahyan, the Emir of Abu Dhabi and first president of the United Arab Emirates (UAE), will operate as a partnership between Great Ormond Street Hospital, UCL, and the Great Ormond Street Hospital Children’s Charity (London, United Kingdom). Construction is scheduled to begin in January 2017 and is expected to be completed by 2018.
Related Links:
Great Ormond Street Hospital for Children
University College London
Great Ormond Street Hospital Children’s Charity
Latest Hospital News News
- Nurse Tracking System Improves Hospital Workflow
- New Children’s Hospital Transforms California Healthcare
- Noisy Hospitals Face Threat of Decreased Federal Compensation
- Orthopedics Centre of Excellence Planned for Guy’s Hospital
- Research Suggests Avoidance of Low-Value Surgical Procedures
- U.S. Federal Readmission Fines Linked to Higher Mortality
- Columbia China to Build New Hospital in Jiaxing
- Dubai Debuts Second Robotic Pharmacy Service
- Seattle Hospital Network Shifts Away from Overlapping Surgeries
- ACC to Launch Valvular Heart Disease Program in China
- Mortality Rates Lower at Major Teaching Hospitals
- South Australia to Inaugurate Upscale Hospital
- Raffles to Launch Second Hospital Project in China
- Research Center Tackles Antimicrobial Drugs Challenge
- Miami Cardiac & Vascular Institute Completes Expansion Project
- Hospital Antibiotic Policies Improve Prescription Practices
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







